Catalyst Wire Dossier Catalyst Wire Dossier

Torezolid phosphate

torezolid phosphate · Trius Therapeutics LLC (a subsidiary of Merck & Co., Inc.)
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Torezolid phosphate, covering 2016-05-03 to 2016-05-03. Get the full timeline:

Most recent: Clinical Trial Update: Exploratory Pharmacokinetic and Bioavailability Study of 2 Capsule Formulations of Torezolid Phosphate [Phase 1]

See pricing